ArticleTherapeutic advances in musculoskeletal disease2020

The switch from etanercept originator to SB4: data from a real-life experience on tolerability and persistence on treatment in joint inflammatory diseases.

Cosimo Bruni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.